Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

HIV-1 strains in humans arose from three independent ape-to-human transmissions in the early 20th century, but the viral adaptation in humans remained unknown until now. Paul Sharp and colleagues from ...

We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health or ... Other strains of HPV can lead to cervical or anal cancer. The human ...